MCK Q3 2024 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q3 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$80.9B+14.8% YoY

Gross Profit

$3.0B3.7% margin

Operating Income

$623M0.8% margin

Net Income

$589M0.7% margin

EPS (Diluted)

$4.42

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$254M

Free Cash Flow

$100M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$66.5B

Total Liabilities

$68.2B

Stockholders' Equity

-$2.1B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80.9B	$70.5B	+14.8%
Gross Profit	$3.0B	$3.0B	+2.5%
Operating Income	$623M	$1.1B	-45.4%
Net Income	$589M	$1.1B	-45.4%

Revenue Segments

U.S. Pharmaceutical Segment

$73.0B90%

International Segment

$3.6B4%

Medical-Surgical Solutions Segment

$3.0B4%

Prescription Technology Solutions

$1.2B1%